Profiel
Linda Basse worked as a Medical Director at Genmab A, Topotarget A, and Zealand Pharma A.
She also served as the Chief Medical Officer at Medivir AB from 2018 to 2020.
Dr. Basse holds a doctorate degree from the University of Copenhagen.
Eerdere bekende functies van Linda Basse
| Bedrijven | Functie | Einde |
|---|---|---|
| MEDIVIR AB | Chief Tech/Sci/R&D Officer | 30-09-2020 |
| ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | - |
| TOPOTARGET A/S | Chief Tech/Sci/R&D Officer | - |
| GENMAB A/S | Chief Tech/Sci/R&D Officer | - |
Opleiding van Linda Basse
| University of Copenhagen | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| GENMAB A/S | Health Technology |
| MEDIVIR AB | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
